Press Releases and Statements

WASHINGTON, DC — Today, the Consumer Healthcare Products Association, the national trade association representing the leading manufacturers and marketers of consumer healthcare products, announced the addition of 41 new members since January 2023, a list which includes 15 manufacturer and 26 associate members, reflecting the broadening self-care landscape across over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices.

“Consumers can be confident that over-the-counter (OTC) acne products containing benzoyl peroxide (BPO) are stable and safe under the specified storage conditions on their labels.

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the following statement today following West Virginia Governor Jim Justice signing Senate Bill (SB) 688 into law. This legislation lifts the annual purchasing limits for common over-the-counter cold and allergy

“While we’re pleased to see positive strides being made on this issue under Dr. Welch’s leadership, specifically when it comes to addressing procedures and timeframes

WASHINGTON, D.C. – Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville released the below statement today following the U.S. House of Representatives passing H.R. 7024, the Tax Relief for American Families and Workers Act., a bipartisan, bicameral tax package that will expand the child tax credit and increase depreciation allowances to promote economic innovation and growth.

Congressmen Curtis, Cárdenas Spearhead Effort

CHPA Senior Vice President of Dietary Supplements Duffy MacKay released the following statement in response to results from a recent trial published in the American Journal of Clinical Nutrition (AJCN), finding that adults ages 60 and older who took a daily multivitamin (MVM) showed a “significantly more favorable change in episodic memory,” reducing cognitive aging by two years compared to those who took the placebo. These results mark the third time a MVM clinical trial within the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) has confirmed the positive benefits MVM’s have on older adults’ cognitive health.

Consumer Healthcare Products Association (CHPA) Vice President of Regulatory & Scientific Affairs Jay Sirois, PhD released the following statement today following the publication of a paper, Safety Considerations for Dietary Supplement Manufacturers in the United States, which he recently co-authored alongside several CHPA manufacturers in the Journal of Regulatory Toxicology and Pharmacology:

Washington, D.C. – The annual Monitoring the Future survey (MTF), conducted by researchers at the University of Michigan and funded by the National Institute on Drug Abuse (NIDA), shows that the percentage of adolescents reporting any substance use in 2023 continues to “hold steady” and remains below pre-pandemic levels, including abuse of over-the-counter (OTC) cough & cold medicines.

(PHILADELPHIA) – The Consumer Healthcare Products Association Educational Foundation (CHPAEF) held its 8th Annual Gala last night at The Bellevue Hotel in Philadelphia. The widely attended event brought together more than 350 attendees from 93 companies across the self-care industry. In addition to highlighting CHPAEF’s key 2023 educational initiatives, the event program also included the unveiling of the Foundation’s new name: Health in Hand, and an announcement on the election of Elizabeth Karvonen, Team Lead of the Emerson Group, to serve as Health in Hand’s new board chair. Elizabeth will succeed previous chair Kyle Stenzel, Senior Vice President of Sales and Global Supply Chain for Combe Inc.

“After urging Governor Hochul to recognize the importance of a more balanced approach to this issue, CHPA was disappointed to see this legislation signed into law today, making New York the only state in the country to unnecessarily limit consumers’ access to a broad range of dietary supplements.

(Washington, D.C.) – Consumer Healthcare Products Association (CHPA) Senior Vice President of Regulatory and Scientific Affairs Lisa Parks released the following statement today regarding the U.S. Food and Drug Administration’s